- Home
- VLGEA vs MXCT Comparison
VLGEA vs MXCT Comparison
Compare VLGEA & MXCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VLGEA
- MXCT
- Stock Information
- Founded
- VLGEA 1937
- MXCT 1999
- Country
- VLGEA United States
- MXCT United States
- Employees
- VLGEA N/A
- MXCT N/A
- Industry
- VLGEA Food Chains
- MXCT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- VLGEA Consumer Staples
- MXCT Health Care
- Exchange
- VLGEA Nasdaq
- MXCT Nasdaq
- Market Cap
- VLGEA 491.9M
- MXCT 398.3M
- IPO Year
- VLGEA N/A
- MXCT 2021
- Fundamental
- Price
- VLGEA $32.38
- MXCT $3.55
- Analyst Decision
- VLGEA
- MXCT Strong Buy
- Analyst Count
- VLGEA 0
- MXCT 3
- Target Price
- VLGEA N/A
- MXCT $8.67
- AVG Volume (30 Days)
- VLGEA 27.4K
- MXCT 627.2K
- Earning Date
- VLGEA 12-03-2024
- MXCT 11-06-2024
- Dividend Yield
- VLGEA 3.09%
- MXCT N/A
- EPS Growth
- VLGEA 0.45
- MXCT N/A
- EPS
- VLGEA 3.40
- MXCT N/A
- Revenue
- VLGEA $2,236,566,000.00
- MXCT $45,599,000.00
- Revenue This Year
- VLGEA N/A
- MXCT N/A
- Revenue Next Year
- VLGEA N/A
- MXCT $21.59
- P/E Ratio
- VLGEA $9.54
- MXCT N/A
- Revenue Growth
- VLGEA 3.23
- MXCT 19.85
- 52 Week Low
- VLGEA $24.42
- MXCT $3.17
- 52 Week High
- VLGEA $33.99
- MXCT $5.55
- Technical
- Relative Strength Index (RSI)
- VLGEA 56.71
- MXCT 48.58
- Support Level
- VLGEA $30.05
- MXCT $3.17
- Resistance Level
- VLGEA $33.24
- MXCT $3.61
- Average True Range (ATR)
- VLGEA 1.04
- MXCT 0.26
- MACD
- VLGEA -0.00
- MXCT 0.00
- Stochastic Oscillator
- VLGEA 69.04
- MXCT 39.09
About VLGEA Village Super Market Inc.
Village Super Market Inc operates a chain of ShopRite supermarkets, a few of which are in northern New Jersey, southern New Jersey, Maryland, and in northeastern Pennsylvania. The company is a member of Wakefern Food Corporation (Wakefern), a retailer-owned food cooperative and owner of the ShopRite name. It consists of one operating segment, the retail sale of food and nonfood products.
About MXCT MaxCyte Inc.
MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.